ADC Bio has won the national 2014 Best for Innovation Award in the British Private Equity and Venture Capital Association’s (BVCA) Management Team Awards.
As announced last month (May) the company had already taken the Wales Regional Award – and has now beaten seven other UK regions to the national prize in the Innovation category.
The Awards recognise the success of the management team in driving innovation through new process technology that helps drug makers to contain complexity and cost in the latest generation of anti-cancer drugs. Accepting the Awards at the BVCA dinner on 18 June, ADC Bio CEO Charlie Johnson commented: “This recognises both three years of technology development work by the team at our Wales facility and the exciting story of antibody drug conjugates (ADCs) in accelerating the fight against cancer.”
Over 150 UK companies were nominated for the 2014 BVCA Management Team Awards, given in each of seven categories. Nominations were subject to an intense due diligence programme and in-depth interviews by the judging panel.